Related references
Note: Only part of the references are listed.Molecular epidemiology of rotavirus gastroenteritis in Japan during 2014-2015: Characterization of re-emerging G2P[4] after rotavirus vaccine introduction
Nusrat Khandoker et al.
JOURNAL OF MEDICAL VIROLOGY (2018)
Rotavirus Vaccination and the Global Burden of Rotavirus Diarrhea Among Children Younger Than 5 Years
Christopher Troeger et al.
JAMA PEDIATRICS (2018)
Shedding of porcine circovirus type 1 DNA and rotavirus RNA by infants vaccinated with Rotarix®
Slavica Mijatovic-Rustempasic et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Serologic response to porcine circovirus type 1 (PCV1) in infants vaccinated with the human rotavirus vaccine, Rotarix: A retrospective laboratory analysis
Htay Htay Han et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines
N. Aliabadi et al.
CLINICAL MICROBIOLOGY AND INFECTION (2016)
Effect of human rotavirus vaccine on severe diarrhea in African infants
Shabir A. Madhi et al.
MALAWI MEDICAL JOURNAL (2016)
Medium- to Long-Term Impact of Rotavirus Vaccination on Hospital Care in Belgium: A 7-Year Follow-Up of the Rotavirus Belgium Impact Study (RotaBIS)
Baudouin Standaert et al.
INFECTIOUS DISEASES AND THERAPY (2016)
Improvement in hospital Quality of Care (QoC) after the introduction of rotavirus vaccination: An evaluation study in Belgium
B. Standaert et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
Adventitious agents in viral vaccines: Lessons learned from 4 case studies
John Petricciani et al.
BIOLOGICALS (2014)
Human rotavirus vaccine (RIX4414) efficacy in the first two years of life A randomized, placebo-controlled trial in China
Rong-cheng Li et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
The human rotavirus vaccine Rotarix™ in infants An integrated analysis of safety and reactogenicity
Hubert Buyse et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Association of serum anti-rotavirus immunoglobulin A antibody seropositivity and protection against severe rotavirus gastroenteritis Analysis of clinical trials of human rotavirus vaccine
Brigitte Cheuvart et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
A Systematic Review of Anti-Rotavirus Serum IgA Antibody Titer as a Potential Correlate of Rotavirus Vaccine Efficacy
Manish Patel et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Investigation of a regulatory agency enquiry into potential porcine circovirus type 1 contamination of the human rotavirus vaccine, Rotarix™ Approach and outcome
Gary Dubin et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Reduction in Pediatric Rotavirus-related Hospitalizations After Universal Rotavirus Vaccination in Belgium
Marc Raes et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2011)
Human Rotavirus Vaccine Is Highly Efficacious When Coadministered With Routine Expanded Program of Immunization Vaccines Including Oral Poliovirus Vaccine in Latin America
Miguel W. Tregnaghi et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2011)
Efficacy, safety and immunogenicity of RIX4414 in Japanese infants during the first two years of life
Naohisa Kawamura et al.
VACCINE (2011)
Immunogenicity, reactogenicity and safety of the human rotavirus vaccine RIX4414 (Rotarix™) oral suspension (liquid formulation) when co-administered with expanded program on immunization (EPI) vaccines in Vietnam and the Philippines in 2006-2007
D. D. Anh et al.
VACCINE (2011)
Immunogenicity, reactogenicity and safety of the human rotavirus vaccine RIX4414 oral suspension (liquid formulation) in Finnish infants
T. Vesikari et al.
VACCINE (2011)
FDA: Benefits of Rotavirus Vaccination Outweigh Potential Contamination Risk
Bridget M. Kuehn
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Co-administration study in South African infants of a live-attenuated oral human rotavirus vaccine (RIX4414) and poliovirus vaccines
A. D. Steele et al.
VACCINE (2010)
Effect of Human Rotavirus Vaccine on Severe Diarrhea in African Infants
Shabir A. Madhi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: Randomised, double-blind, controlled study
K. B. Phua et al.
VACCINE (2009)
Immunogenicity of The Oral Live Attenuated Human Rotavirus Vaccine RIX4414 (Rotarix™) Oral Suspension (Liquid Formulation) Co-administered with Childhood Vaccinations in Panama
A. A. Velasquez et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2008)
Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants:: a randomised, double-blind, placebo-controlled phase III study
Alexandre C. Linhares et al.
LANCET (2008)
Coadministration of RIX4414 Oral Human Rotavirus Vaccine Does Not Impact the Immune Response to Antigens Contained in Routine Infant Vaccines in the United States
Penelope H. Dennehy et al.
PEDIATRICS (2008)
Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study
T. Vesikari et al.
LANCET (2007)
Immunity and correlates of protection for rotavirus vaccines
MA Franco et al.
VACCINE (2006)
Serum antibody as a marker of protection against natural rotavirus infection and disease
FR Velázquez et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Share Paper
